DK1057828T3 - Orale trovafloxacin-suspensioner - Google Patents

Orale trovafloxacin-suspensioner

Info

Publication number
DK1057828T3
DK1057828T3 DK00304550T DK00304550T DK1057828T3 DK 1057828 T3 DK1057828 T3 DK 1057828T3 DK 00304550 T DK00304550 T DK 00304550T DK 00304550 T DK00304550 T DK 00304550T DK 1057828 T3 DK1057828 T3 DK 1057828T3
Authority
DK
Denmark
Prior art keywords
suspensions
crystals
trovafloxacin
oral
novel
Prior art date
Application number
DK00304550T
Other languages
English (en)
Inventor
Douglas John Meldrum Pfi Allen
Sojka Sonja Pfizer Cen Sekulic
Daniel Ray Pfizer Cent Arenson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1057828T3 publication Critical patent/DK1057828T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
DK00304550T 1999-06-04 2000-05-30 Orale trovafloxacin-suspensioner DK1057828T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13746399P 1999-06-04 1999-06-04

Publications (1)

Publication Number Publication Date
DK1057828T3 true DK1057828T3 (da) 2003-07-14

Family

ID=22477550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00304550T DK1057828T3 (da) 1999-06-04 2000-05-30 Orale trovafloxacin-suspensioner

Country Status (10)

Country Link
US (1) US6239141B1 (da)
EP (1) EP1057828B1 (da)
JP (1) JP3465820B2 (da)
AT (1) ATE234835T1 (da)
BR (1) BR0002577A (da)
CA (1) CA2311112A1 (da)
DE (1) DE60001687T2 (da)
DK (1) DK1057828T3 (da)
ES (1) ES2194677T3 (da)
PT (1) PT1057828E (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU773218B2 (en) * 1999-10-08 2004-05-20 Debiopharm International Sa Fab I inhibitors
JP2004535370A (ja) * 2001-03-05 2004-11-25 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 味をマスクした液体製薬学的組成物
DE60230934D1 (de) * 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
US20030068829A1 (en) * 2001-06-25 2003-04-10 Symyx Technologies, Inc. High throughput crystallographic screening of materials
CA2453182A1 (en) * 2001-07-10 2003-01-23 Meredith L. Greene Crystalline thiazine oxazolidinones
EP3168218B1 (en) 2001-08-15 2018-11-14 Pharmacia & Upjohn Company LLC A crystal comprising an l-malic acid salt of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide for use as a medicament
MXPA04008720A (es) * 2002-03-12 2004-12-06 Squibb Bristol Myers Co Suspension oral de sabor agradable y metodo.
WO2003093322A2 (en) * 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
US8367098B2 (en) * 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
JP4859460B2 (ja) * 2002-12-06 2012-01-25 アフィニウム ファーマシューティカルズ， インク． ヘテロ環化合物、その製造方法および治療におけるその使用
CA2519429C (en) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
WO2007053131A2 (en) 2004-06-04 2007-05-10 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as antibiotic agents
CA2632476A1 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
CA2658506C (en) 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab 1 inhibitors
WO2008098374A1 (en) * 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
WO2013190384A1 (en) 2012-06-19 2013-12-27 Affinium Pharmaceuticals, Inc. Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
MX2018010254A (es) 2016-02-26 2018-12-19 Debiopharm Int Sa Medicamento para el tratamiento de infecciones de pie diabetico.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5266559A (en) 1989-10-27 1993-11-30 Firmenich S.A. Use of unsaturated macrocyclic lactones as perfuming ingredients
US5391763A (en) 1990-07-11 1995-02-21 Pfizer Inc. 3-aza-bicyclo[3.1.0]hexanes which are intermediates for anti-bacterial azabicyclo quinolone carboxylic acids
TW271400B (da) 1992-07-30 1996-03-01 Pfizer
ES2117426T3 (es) 1995-06-06 1998-08-01 Pfizer Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
KR100343909B1 (ko) * 1995-08-29 2003-04-10 화이자 인코포레이티드 트로바플록사신의쯔비터이온형태
TR199800340T1 (xx) * 1995-08-29 1998-06-22 Pfizer Inc. �n-ila� 6-N-(L-ALA-L-ALA)-trovafloksasin polimorflar�.
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids

Also Published As

Publication number Publication date
EP1057828A3 (en) 2001-05-16
US6239141B1 (en) 2001-05-29
EP1057828A2 (en) 2000-12-06
CA2311112A1 (en) 2000-12-04
JP3465820B2 (ja) 2003-11-10
DE60001687T2 (de) 2003-12-18
BR0002577A (pt) 2001-01-02
DE60001687D1 (de) 2003-04-24
ATE234835T1 (de) 2003-04-15
EP1057828B1 (en) 2003-03-19
ES2194677T3 (es) 2003-12-01
PT1057828E (pt) 2003-07-31
JP2000344770A (ja) 2000-12-12

Similar Documents

Publication Publication Date Title
DK1057828T3 (da) Orale trovafloxacin-suspensioner
IL165715A0 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
EA199901014A1 (ru) C-4"-замещенные макролидные производные
CY1111693T1 (el) Αντιιικοι παραγοντες
WO2003064431A3 (en) Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
BG101118A (en) Therapeutical compounds
CA2292359A1 (en) Novel azalides and methods of making same
YU41500A (sh) Novi makrolidi
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
DK1200412T3 (da) Antiproliferative imidazolforbindelser
NO996108L (no) 9-oksinerytromycinderivater
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
TR200102128T2 (tr) Ketolid antibiyotikler
EE05091B1 (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
GT199900208A (es) Antibiòticos cetòlidos carbamato y carbazato.
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
DE69917717D1 (de) C11-Carbamate von antibakteriellen Makroliden
DE60208404D1 (de) Kreuzverquerte glycopeptid-cephalosporin-antibiotika
AP9801377A0 (en) Tricyclic erythromycin derivatives.
AP9801235A0 (en) Erythromycin derivatives.
ATE397615T1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
ATE286728T1 (de) Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen
BR9902049A (pt) Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina.
GB9926301D0 (en) Novel compounds